Vinod Ravi, MD, is an Associate Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine. He is also the Clinical Director, Translational Research Accelerator Program, Department of Genomic Medicine, Division of Cancer Medicine, and holds a joint adjunct appointment as an Associate Professor, Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer.
Dr. Ravi’s clinical practice is focused on vascular sarcomas such as angiosarcoma and epithelioid hemangioendothelioma. Dr. Ravi is also part of the angiosarcoma and leiomyosarcoma working groups at MD Anderson to efficiently utilize the current moonshot platforms to improve outcomes in these rare diseases. Over the course of the last 8 years that he has been at MD Anderson, he has conducted several Phase II and III studies in patients with sarcoma. His clinical research interests are in the development of novel therapies for angiosarcoma and other vascular tumors.
From a data science standpoint, his research focus is utilization of multi-dimensional clinical and molecular data for identification of effective molecular therapies. Dr. Ravi is interested in correlating responses to specific targeted therapies with molecular predictors to improve clinical trial efficiency and success rates. As the clinical director of TRA (Translational Research Accelerator) program, Dr. Ravi leads the implementation of big data initiative that connects molecular data on patient samples with clinical and radiological information from electronic records.
